Objective Psychosocial risk screening is an important initial step in delivering evidence-based care. This qualitative descriptive study identified how multidisciplinary pediatric oncology health-care providers perceive psychosocial risk screening to identify factors in uptake and implementation. Methods A script guided digitally recorded (transcribed) interviews regarding psychosocial screening and challenges to facilitators of screening. Participants were 15 multidisciplinary staff (physicians, nurses, social workers, psychologists, physician assistant) at nine sites, three using the Psychosocial Assessment ToolV C for research and six for clinical care. Constant comparative analysis was used to analyze the independently coded interviews. Results Thematic content analysis identified an overarching theme -Screening is important because it facilitates clinical care -and four subthemes: Optimizing Psychosocial Care, Implementing Screening, Engaging Families, and Utilizing Clinical Pathways. Conclusions Findings support the importance of integrating psychosocial risk screening into clinical care and offer strategies for implementation of screening across a range of settings.
Recommendations, Assessment, Development, and Evaluation as an evaluation approach (Guyatt et al., 2008) . While the assessment standard provides strong background evidence for screening, there is little evidence in the standard, or elsewhere, for the extent of uptake in clinical practice or how screening can be conducted considering potential barriers to its implementation. In a survey of psychosocial services provided within the first month after a child's cancer diagnosis at Children's Oncology Group sites, <10% of sites reported using empirically supported psychosocial evaluations (Selove, Kroll, & Coppes, 2012) .
Assessment of psychosocial risk related to the child and the family, particularly when completed early in the cancer diagnostic and treatment process, provides a means by which evidence-based interventions can be matched to specific child and family needs over the course of treatment and beyond. This may have important implications for the delivery of quality care to these patients and families. An important but less considered potential contribution of screening is how it might help reduce health disparities in pediatric cancer (Bhatia, 2011) . Factors such as language, socioeconomic status, social isolation, "financial toxicity," child behavioral difficulties, parental distress, and cultural values and beliefs may contribute to disparities by limiting engagement in care or adherence to treatment (Bona, London, Guo, Frank, & Wolfe, 2016; Gupta, Wilejto, Pole, Guttman, & Sung, 2014; Kent, Sender, Largent, & Anton-Culver, 2009; Lightfoot et al., 2012) . These are factors that can be identified in systematic psychosocial risk screening. Access to care and disparities in treatment outcomes are examples of why language and cultural adaptations of screening instruments are particularly important for screening (Patel et al., 2013; Sharib et al., 2014) .
Screening necessitates availability of validated approaches. In a systematic review of screening models and instruments in pediatric cancer (Kazak et al., 2012) , two were identified-the Distress Thermometer (DT; NCCN, 2003) and the Psychosocial Assessment ToolV C (PATV C ; Pai et al., 2008) . The DT is a brief screening approach modeled after pain scales. It provides a unidimensional rating of individual distress on a 10-point scale, with an optional problem list (National Comprehensive Cancer Network, 2003) .
To our knowledge, the PATV C (Pai et al., 2008; Kazak, Schneider, DiDonato, & Pai, 2015) is the only validated brief parent report screener of family psychosocial risk. It is based on a social ecological model that assesses psychosocial risks across the child's social environment. The PATV C has an all-literacy (4th grade) reading level and generates a total score and subscale scores (e.g., structure/resources, family problems, social support, stress reactions, family beliefs, child problems, sibling problems). The total score maps on to the Pediatric Psychosocial Preventative Health Model (PPPHM; Kazak, 2006) . The PPPHM is based on a public health pyramid model, with three tiers of risk-Universal, Targeted, and Clinical-and with implications for different levels of clinical care based on risk level (Figure 1 ). The PATV C has been used primarily in pediatric cancer, in the United States and other countries (Barrera et al., 2014; Karlson, et al., 2013; McCarthy, Clarke, Vance, Ashley, Heath, & Anderson, 2009; Sint Nicolaas et al., 2016) , with adaptations for other diseases, including sickle cell disease (Crosby et al. 2016; Karlson et al., 2012) , organ transplantation (Pai, Tackett, Ittenbach, & Goebel, 2012) , inflammatory bowel disease (Pai et al., 2014) , and congenital heart disease (Hearps et al., 2014) .
With instruments available for screening in pediatric cancer and clear mandates for its inclusion in clinical care, the absence of routine and/or systematic screening is of concern, as it may limit the quality of care provided and hamper the ability to address disparities. Potential barriers to psychosocial care delivery in general (Selove et al., 2012) and screening more specifically (Kazak, DiDonato, Schneider, & Pai, 2016) have been suggested, including stigma associated with behavioral concerns and treatment, unrecognized needs of patients/families, concerns about how to respond to identified risks, time required for screening, impact on staff workflow, and how to maintain and sustain screening as a core component of pediatric oncology care. These barriers have not been explored in research. In addition, there are no reports of how health-care providers view screening and its feasibility. That is, it is not known how frontline health-care providers view the expert consensus recommendations.
To understand factors that may influence the uptake and implementation of screening from multidisciplinary perspectives, a qualitative descriptive approach was used, with a focus on screening in general as well as screening with the PATV C to identify key factors necessary for broader implementation of screening (Sandelowski, 2000) . Because the PATV C is unique as a screener of family psychosocial risk and because it is used quite widely in pediatric cancer centers, understanding factors related to its use is an important step in refining and expanding screening.
Method

Design
This study is a qualitative analysis of interview data from 15 multidisciplinary health-care providers regarding the uptake and implementation of psychosocial risk screening, with a focus on the PATV C and on screening in general. 
Participants
Purposeful criterion-based sampling (Patton, 2002) allows for the careful selection of participants who will provide the "richest information for the research questions" (Wu et al., 2016) . This sampling approach was used to identify 15 multidisciplinary pediatric oncology health-care providers who met the following inclusion criteria. Nine participants were from a Research Site where PATV C research was in progress (three each from AIDHC, CHOP, and MDA). These participants were aware of the PATV C and the study but were not collecting data nor involved in the details of the study protocol. These sites do not conduct clinical screening, outside of the study protocol. And, except when highrisk "red flag" items are endorsed, the screening results are not used for clinical purposes. Six other participants, psychologists or social workers, were each from one of six Clinical Sites where the PATV C was being used for clinical care. Each of these six participants directly used the PATV C in clinical care.
1 These six Clinical Sites were selected to assure a range in terms of size, patient population, and geographic location, with particular attention to areas of the United States with higher portions of Spanish-speaking populations (e.g., Texas, California, Florida). For all participants, their use of the PATV C was assumed to be emblematic of their overall interest in screening and their ability to provide insights not only about the PATV C but also about screening in general. All three research sites and three of six clinical sites used the Spanish version of the PATV C , in addition to the English version.
Participants represent a diversity of key professions, including psychologists (n ¼ 4), social workers (n ¼ 5), pediatric oncologists (n ¼ 3), nurses (n ¼ 2), and a physician assistant (n ¼ 1) (see Supplemental Table I for a detailed description of the participants). Thirteen of the participants were female and two male. The initial sample size of 15 health-care providers was based on the expected number of participants needed to reach redundancy and data saturation in this qualitative analysis (Sandelowski, 1995; Wu et al., 2016) . Throughout the iterative data analysis procedure, we assessed redundancy (is there consistency in the interview information) and saturation (are new themes emerging in the interviews). The sample size of 15 was sufficient to achieve redundancy and saturation. participants at institutions other than their own between February and August 2015.
2 Participants were sent copies of the PATV C in English and Spanish, a figure of the PPPHM, a brief description of the larger study, and a consent form in advance of the interview. Participants were asked to provide feedback on the PATV C and on screening in general with particular attention to how screening can be integrated into clinical care, linked to resources and interventions, and how it can impact health disparities. In accordance with the institutional review board approval for this study, written informed consent was obtained before beginning the interview (those interviewed by phone consented verbally and returned the signed form via email). Following consent, the interviewer reviewed the previously sent materials. Professional transcriptions of the electronically recorded qualitative interview were reviewed by the interviewers to assure accuracy of transcription.
The Interview Script
The investigator team developed a three-part semistructured interview script (Brédart et al., 2014) to gather feedback about screening for psychosocial risks in general as well as specific thoughts about using the PATV C for screening (the detailed script is in supplemental materials). Each part was approximately 15 min (sample questions are noted below). Part 1 addressed screening in general (e.g., not specifically the PATV C ): When should screening take place? What cultural beliefs and/or practices should be considered in screening or in interpreting the results of screening? Part 2 focused specifically on challenges to screening generally and including the PATV C : What are the barriers to screening in your setting? What resources would be necessary to use the PATV C or another screener more systematically? Are there other barriers (probe about labeling/stigma, time, impact on workflow)? Part 3 was used only for hospitals that were using PATV C clinically: Tell me briefly how the PATV C is used in your setting. Do you use the Spanish version of the PATV C ? The script was used flexibly, with attention to major topics and the flow of the interview to elicit the most valuable data from the person being interviewed (e.g., not every probe was asked of each participant if that information was gathered in response to a prior question).
Data Management and Analysis
The transcribed interviews were Microsoft Word documents that were uploaded into ALTAS.ti V C . Initial analytic activities were based on principles of thematic content analysis that are used to inductively analyze the qualitative data and ultimately identify themes (Hsieh and Shannon, 2005) including being sensitive to the study questions (PATV C 's feasibility and relevance including cultural beliefs and practices that may need to be taken into consideration when implementing the PATV C ; Elo et al., 2014) .
Codes (concrete) and themes (more abstract statements that fully describe the coding categories) were developed from the data through a process of constant comparative analysis. Using this technique, the investigator simultaneously collects information through interviews, reads interviews as individual cases, disassembles interviews through coding categories, rearranges coding categories into patterns, and reintegrates the patterned categories into a conceptualization that encompasses the experiences of all participants (Glaser, 1992) .
The rigor of the iterative analytic process was guided by NIH standards for qualitative research (OBSSR, 2001 ) and those of this journal (Wu et al., 2016) . Coders were trained to rigorously and systematically gather, manage, analyze, and interpret qualitative data following the recommendations of Wu et al. (2016) . This training and subsequent in-person supervision of the qualitative analyses were conducted by an expert qualitative researcher (J.D.). The four-member investigator team first independently coded three interviews, selected to represent different professions and study sites, to define an initial set of codes. Subsequently, they met as a group to create a coding structure (codebook), which consisted of 54 discrete codes. For the remaining interviews, each transcript was coded independently by two of three other members of the research team (M.M., A.L., N.R.). The coders then discussed each interview and reconciled any discrepancies. The PI (A.E.K.) reviewed all the coded transcripts and provided feedback to the coders, who made any additional minor changes in the coding agreed on by both individuals. All coded material from the interviews was organized and managed in ATLAS.ti V C and reviewed by the full research team who extracted six themes from the codes. For example, the theme of Challenges and Facilitators to Screening was inclusive of codes such as Advantages of Screening, Impact on Workflow, Responding to Identified Risks, and Technical Issues. These six themes were subsequently collapsed into an overarching theme and four subthemes, based on a discussion of the project team to more coherently communicate the results.
Results
The overarching theme of the health-care provider interviews was that screening is important because it facilitates clinical care. Four subthemes were identified that further explain why screening in general is important and highlight issues relevant to its implementation in clinical settings: Optimizing Psychosocial Care; Implementing Screening; Engaging Families; and Utilizing Clinical Pathways. The findings are organized by subtheme. Illustrative direct quotes from participants are used to further describe key points. All themes and examples of each are summarized in Table I .
Optimizing Psychosocial Care Screening in general was viewed as critical to advancing proactive, rather than reactive, care including assessments and interventions aimed at facilitating patient and family adjustment to child's cancer diagnosis. Significant problems can be prevented if needs are identified and met early in the cancer treatment. Participants noted that screening is an efficient and effective means by which to match interventions to specific needs, especially in the context of limited institutional resources. Screening was linked to potential positive outcomes by promoting family functioning that supports medication adherence and attendance at clinic visits, the child's health-related quality of life, and parent coping and adaptation. In addition, screening was identified as facilitating communication across the team regarding family needs and partnership with the family to promote care of the child with cancer.
To facilitate the systematic identification of families who will benefit from psychosocial care, participants consistently stated that no families should be excluded from screening. It is important to think broadly about who might be at a higher risk to reduce the chance of missed identification of families who experience hardships: ". . . I think you run the risk of making assumptions of people who may or may not need it." To providers, a family may seem "normal," but screening allows for underlying psychosocial issues to surface and gives providers insight into the needs of families during this stressful period. Several participants talked about the importance of their center taking time to plan for successful implementation of screening. This includes determining who should administer the screener as well as how results can be effectively communicated to key health-care team members.
The participants agreed that consistent implementation and utilization of screening requires health-care providers to recognize, understand, and appreciate its importance in helping achieve clinical care goals-this principle was sometimes referred to as "buy in" or "ownership": "I think that once the value of screening becomes evident. . . once there is benefit to both patients and families and the clinical team to having a standardized approach, then I think the widespread team would be very supportive." Similarly, another stated, "I think once healthcare team members see . . . that there are results that we can use out of this, I think certainly our practitioners would be very interested in this." Champions, professionals who play a central role in raising awareness and advancing the benefits of screening, are necessary when introducing a psychosocial screening procedure in a center or clinic. Champions promote the importance of a new practice by presenting its value and practicability in a compelling manner to colleagues, "You have to elevate the understanding of psychosocial risk factors of a family. . . for screening to be taken seriously." Those interviewed saw potentials for all types of professionalsmedical, nursing, and psychosocial-to be champions for the psychosocial screening of patients and their families. Emphasis was also given to the importance of clinical leaders (e.g., division chiefs and nurse managers) endorsing the practice to promote acceptance.
Administrators in health-care settings are tasked with allocating and budgeting resources for patient care. While resources are needed to implement screening, largely in terms of staff to conduct the screening and provide services, participants commented that they were surprised at how many families scored in the low-risk category, which may conserve resources. One noted that it had helped reduce unnecessary referrals and decrease the overall number of referrals: ". . .percent-wise we are doing less consults, where now we're meeting everybody but we're doing less full consults. . . . it actually helped us in that sense." One participant indicated that they previously provided consultations for all families scoring at the clinical level of the PPPHM (Kazak, 2006) . They subsequently changed to initiate automatic referrals for families at the targeted level as well and found that this change facilitated efficient care delivery.
The link between time, cost, and potential cost benefit, was also noted, ". . .We pay a significant amount of lip service to it, but to then apply that to general practice where you have to allocate resources and spend dollars is different so you need that institutional memory that demonstrates that, hey, this was a big problem. We could have intervened early and look at this bullet that we dodged with this family by offering X, Y, and Z." Finally, strong endorsements of screening were stated by health-care providers who had incorporated screening into their practices: "It makes our job easier, and I also feel I can be much more effective in my work." Another emphasized, "I think it's an important thing to do and I don't have to do it. I choose to do it. . .I do find that personally it's important to my practice."
Implementing Screening
In practice, initial screening using the PATV C was conducted between 24 hours after diagnosis to up to 1 month later. Participants indicated that the earlier the screening occurs, the better the outcomes for families may be: "We currently do not repeat it, but we've definitely moved forward with the idea that needs change throughout treatment. I frequently say to familieswhere you are when you're first diagnosed might not be the same place you are two months/three months later." Indeed, almost all participants recommended that screening be repeated to capture changes over time: "I think a good point would be around six months or any change in treatment or change like relapse or starting radiation."
Time to complete screening, from the perspective of both the family and staff, is a challenge. Families are often overwhelmed at diagnosis, and completing a screener necessitates time, effort, and a quiet space. Concern was expressed about "survey fatigue" and the frustrations experienced by some families with lower literacy or for whom English is not their first language. For staff, it can be necessary to sit with some families to complete screening, and this can take up to 40 min, or more than one session, in a few cases. There is a concern that screenings occur in a timely manner to identify and activate needed services. In contrast, for some centers that integrated the PATV C into their workflow, it was noted that time is not a concern and the impact on workflow was routinized, ". . . the parents fill it in themselves . . . I just kind of leave it with the families. I just take a few minutes to explain that, you know, it's just three pages, it's just a way for me to get to know you and your family. So for me it's pretty minimal and even the scoring doesn't take all that long really."
Although social workers (most frequently) and nurses conduct screening, nuances related to roles were noted: ". . .the social workers . . . were very clear that they don't want to do it. Not because they don't support screening but because they do an assessment with every new patient . . . they see it as taking up more time." "I think it's a lot to add to the nurses' plate to do the screening. Not that they can't, but new patients coming in, there's so much education and everything that's done. This would just be one more thing." Having the people to provide services was an important consideration in terms of implementing screening: "If you don't have the resources to answer the question, you're less likely to ask the question." More broadly, resources are related to how the screening is used and health-care costs: "So I think in terms of healthcare costs in general, having the ability to determine how to allocate resources and I would be thinking about employee resources."
With regard to PATV C , technical resources are required. The PATV C was usually administered on a tablet computer and this was seen as easier and less intimidating than using the paper version. However, the paper version was used in settings without access to a tablet or computer. A number of comments pertained to the importance of making electronic versions accessible, and resolving technical issues related to passwords, safe data storage, and inclusion in the electronic health record (EHR). Accessible training resources to facilitate the use of the PATV C , including guidance on scoring, interpretation, and clinical care were seen as valuable next steps that could further enable broader implementation.
Engaging Families
Partnering with families is facilitated by screening in general. Advantages of screening included its acceptability to families and the inclusion of the "family voice" in the assessment process: "I give it to all newly diagnosed patients with a malignancy. I can't remember a family that ever has refused to fill it out." Engaging families in a process of screening, characterized by relationships of trust, was identified as an important requisite. Participants identified improved understanding of families' situations and concerns, increased matching of education to gaps in family knowledge and understanding, and partnership through discussion of results with families as benefits of screening. This was seen as consistent with familycentered care. Potential challenges include situations in which family beliefs may include concerns about sharing "private" information, a consideration that is accentuated by potential uncertainty associated with the EHR. Participants noted that in situations where families were difficult to engage, screening keeps a focus on relevant information and helps staff engage with families.
The participants agreed that cultural influences may increase the complexity of the content and process of screening for psychosocial risk in general; however, it was not seen as a reason to forego screening because potential issues driving health disparities may not be identified otherwise. Participants thought that the questions used in screening must be sensitive to cultural differences and not reflect stereotypical ideas. While specific suggestions were not made regarding the wording of items on the PATV C , or any other psychosocial screening instrument relative to cultural issues, participants suggested that screening should avoid questions that may be confusing, negative, or offensive because of cultural differences. Plus, the broadest possible conception of culturally related issues like gender, decision making authority, religion, and role responsibilities to avoid cultural bias are important. Participants were also concerned that families may not disclose information during the screening process and accept assistance regarding the issues being discussed in screening because of their cultural beliefs about privacy and their fears about disclosing perceived areas of failure. Suggestions included the presence of a diverse staff and a welcoming environment for diverse patients and families as well as the importance of consistency and trust building.
Language was identified as a potential barrier to screening in general. First, the availability of quality interpreters was a concern for those who are being screened in a language that is not their primary language. A participant related a concern about a parenting dyad in which one spoke English and the other parent did not, "I think the other thing that you have to be so careful about is when one parent speaks fluent English and the other one doesn't. And then you're relying on the father to translate . . . sometimes that can be a problem." Second, the complex semantics needed for expressing emotion-laden content must be considered. One specific example was given about an item on the PATV C , "This is a disaster," by a participant who said that some of the families say anything that goes poorly is a disaster and that this item may actually be seen as minimizing their suffering.
Trained, skilled, and diverse staff are important for implementation of screening. That is, the Spanish version of the PATV C was seen as an advantage in centers with a large Spanish-speaking population and was used when staff spoke Spanish. Some families are bilingual, which highlights uncertainty about when to use the Spanish version: "Having something in Spanish to help with screening these families is huge in my population." "I felt more comfortable [using] paperwork in Spanish. I feel like with that situation it was effective, 'cause it gave me a window into some other things that maybe did not come up in conversation, but um. . . but, you know, he did speak some English, too."
Utilizing Clinical Pathways
More than half the participants reported that the advantage and importance of screening in general lies in prevention of crises by intervening early based on screening results. The key is to develop specific clinical pathways linking screening and specific recommendations. For example, a "response and communication plan" might be used to facilitate treatment planning amongst members of the health-care team, or a treatment plan could be shared with the family in a timely manner based on screening results and including specific intervention steps. It was noted that more attention to this step is needed because it is novel (e.g., pathways do not exist at this time). There was a range of methods described for communicating results including informal discussions among team members, planning at psychosocial case conferences, provision of an email summarizing screening results, scanning results into the EHR, or preferably full integration of the screener in the EHR.
Participants also noted that psychosocial interventions are more effective when matched to needs (i.e., cancer center staff can "use the right resources for the right families"). While acknowledging limited resources, there was recognition that there are staff, financial resources, and foundation-based supports available to families with identified needs, and screening provides a roadmap for connecting families to appropriate resources. Screening ensures families receive the care they need and reduces the provision of care families do not need. That is, screening provides for tailoring services to each family's needs. However, the importance of informing families of what is outside the realm of possibility in terms of provision of supports and services was highlighted as the specific services available in a setting will direct how needs identified through screening can be addressed.
Screening in general promotes more positive medical and psychosocial outcomes, according to the participants, by guiding the team on how to promote parenting and family functioning to support adherence, the child's quality of life, and parent coping. That is, "I think as you're able to address . . . whatever the stressors the family is experiencing at the time . . . and alleviate some of those stressors, families will be able to prioritize more, taking care of the child who's sick, and making sure that they're getting to their appointments, making sure that they're getting their medication or their treatment at home and they will be able to meet those needs more independently if those stressors are reduced."
Discussion
The perspectives of multidisciplinary health-care providers on screening are critical to understand the efforts to implement psychosocial risk screening approaches in pediatric health care. This information has not previously been reported in a research study. Based on qualitative interviews with multidisciplinary pediatric oncology health-care providers, there is strong support for psychosocial risk screening in general, for assuring that screening is universal (e.g., for all patients) and for screening in a systematic manner, integrated into routine clinical care. At the same time, the data confirm the presence of challenges in the process of linking screening results to overall provision of psychosocial care. Screening in general allows for early (preventative) identification of risk factors that can be linked to clinical pathways of care and matched to the needs of patients and families.
Screening in general also has potential impact in reducing health disparities. Participants in this study had not explicitly considered screening as an approach to improving health equity. However, participants acknowledged that factors that contribute to disparities (e.g., financial concerns, social isolation, family problems, child problems, language barriers) are apparent and their reliable screening can be essential in targeting resources appropriately. Undetected and untreated psychosocial risks can increase the likelihood of poorer medical and psychosocial outcomes. Universal psychosocial screening is recognized as necessary early in treatment to ensure optimal, efficient care and access to evidence-based psychosocial services for all families. Screening can also enhance clinical care, in part, because it offers a means by which health-care providers can join with families and engage them in the process of decision-making about psychosocial care. There is preliminary evidence that providing health-care teams with feedback about psychosocial risk screening findings may reduce risk over time and improve pain outcomes (Barrera et al., 2014) . Screening was seen as acceptable to families and helpful in engaging with families where health inequities may be a concern. For example, the use of the Spanish version of the PATV C was valued in settings with Spanish-speaking staff. The lack of screeners in other languages was noted to be a barrier.
The health-care providers highlighted the value of recognizing problems early in treatment to remediate existing problems and prevent others. Screening also allows for matching services with family needs and for treatment of problems that may have the potential to escalate. This is an approach that uses often limited existing resources prudently and may have implications for patient safety and satisfaction, as well as overall value and quality of care (Porter, 2010) . For example, early recognition of emotional concerns in a child or parent, or disclosure of family problems that could disrupt treatment, provides timely opportunities to intervene and reduce risk to all involved in the patient's care (Mullins, Tackett, & Suorsa, 2016) . Similarly, given the evidence for acceptability of screening to families, screening in general may improve engagement with the health-care team and facilitate psychosocial care consistent with the standards (Wiener et al., 2015) .
The interviews covered the issue of urgent situations (e.g., suicidality or lack of resources to purchase medicine); however, participants did not identify these as challenges to screening, presumably because it is necessary to manage these in clinical care regardless.
Having broad information about a patient and family was the primary interest. This is consistent with an earlier finding that families found to be at higher levels of risk received more intensive psychosocial services than those at lower risk, indicating that the screening process works as intended, providing care where and when most needed (Kazak et al., 2011a) . Highlighting the efficiency and potential cost-effectiveness of screening, several participants mentioned that screening documented that many families score within the low-risk tier of the PPPHM (Universal). In this way, fewer referrals to psychologists were made, lessening the likelihood of "false positives," or unnecessary care.
Challenges to screening are closely linked to the provision of psychosocial care in busy and potentially underresourced health-care settings. These include the time necessary to screen (and to follow up with identified needs), determination of who will have responsibility for screening, and overcoming any technical challenges entailed in computer-based entry and storage for sensitive data. Although it was shown that screening can be completed within 24-48 hours of a cancer diagnosis using a paper and pencil version of the PATV C (Kazak et al., 2011b) , web-based screeners that can be used on a tablet or computer may reduce the effort required by staff, thereby limiting concerns about time and effort involved in screening. In addition, the timing of screening, an important consideration in the implementation of screening, has not been evaluated to date. Testing ways in which screening could be repeated at key points in the cancer treatment trajectory is a needed step. Linking screening to psychosocial care brings up broader issues related to psychosocial staffing in pediatric cancer programs and the importance of identifying effective models of clinical care.
It is a potential limitation that all participants were at institutions using the PATV C , whether in a research study or in clinical practice. The interview questions were constructed to be inclusive of all types of psychosocial screening. The data were interpreted as broadly as possible and without any emphasis on concerns or issues that were specific to a specific approach or measure to provide results that would be optimally generalizable. In this way, the study was able to describe actual and anticipated experiences with screening, which may be helpful to sites that are considering use of a screener. However, sites that do not screen systematically may have other views on the importance of psychosocial screening or concerns or barriers that could not be identified in this study. There are a number of other methods by which psychosocial screening can be accomplished (e.g., DT, symptom specific questionnaires), and perspectives on and barriers to the implementation of these approaches warrant further exploration.
Psychosocial risk screening in pediatric cancer is at an early stage in the process of implementation research. Using a qualitative approach enabled the identification of several key areas for future study. First, in screening approaches, it is important to address language, culture, and related factors that facilitate engagement, communication, and collaboration with families. Not having validated screeners available in languages other than Spanish and English may increase the likelihood that the needs of high-risk families will be missed. Second, research on processes of implementation and the development and testing of clinical pathways linking screening with psychosocial care are critical next steps. These efforts necessitate delineation of the organization, staffing, and services provided in a range of treatment sites. Even in settings providing screening and psychosocial services (Selove et al., 2012) , how services are provided, how services are selected, and determination of specific services to offer to families is unknown. Third, questions of when and how often to screen are important considerations that warrant research to identify key points for rescreening and test of the relevance of existing measures to capture critical information at varying points in the treatment process. Finally, while psychosocial risk screening has the potential to reduce health-care costs, by delivering effective and efficient psychosocial care, matched to the needs of patients and families, research on cost-effectiveness of screening is necessary.
While the present study focuses on pediatric cancer, its implications are broader. The PATV C was developed to be generalizable across illness groups and is used in other patient populations with only minor modifications specific to other diseases and treatment approaches. Screening for psychosocial concerns is included in recently published international guidelines for Type I diabetes (Delamater, de Wit, McDarby, Malik, & Acerini, 2014) , and screening patients aged 12 years for anxiety and depression is a recommended part of care in cystic fibrosis (Quittner et al., 2016) . While the majority of centers treating children with diabetes report screening for psychological problems (generally with an interview or rating scale), a lack of staff and funding for staff to screen were noted to be concerns in the delivery of this care (de Wit, Pulgaron, PatinoFernandez, & Delameter, 2014) . In cystic fibrosis, this is being addressed by placing mental health coordinators in clinics (Cystic Fibrosis Foundation, 2016) . Identifying common approaches and challenges across illness groups may facilitate the uptake of psychosocial screening in pediatric settings. Ongoing attention to strategies that support screening and potential challenges as well as evaluation of the impact of screening on care delivery remain important next steps in this research.
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